-
Document de presse | 2022.05.03
Development of an ensemble model to anticipate short-term COVID-19 hospital demand
For the past two years, the COVID-19 pandemic has exerted pressure on the hospital system, with consequences for patients' care pathways. To support hospital planning strategies, it is important to anticipate COVID-19 health care demand and to continue to improve predictive models.In this study published in the journal PNAS, scientists from the Mathematical Modeling of Infectious Diseases Unit at...
-
Document de presse | 2021.05.27
COVID-19, one year on: persistence of protective antibodies and significantly reduced risk of reinfection
A study conducted by the University Hospital of Strasbourg (HUS) in collaboration with the Institut Pasteur, published as a preprint on medRxiv, has led to a significant advance in knowledge about COVID-19.In connection with the SeroCoV-HUS study led by Professor Samira Fafi-Kremer (University Hospital of Strasbourg (HUS) – University of Strasbourg – INSERM UMR1109), the team at Strasbourg...
-
Document de presse | 2021.05.05
COVID-19: discovery of the mechanisms of short- and long-term anosmia
Loss of smell, or anosmia, is one of the earliest and most commonly reported symptoms of COVID-19. But the mechanisms involved had yet to be clarified. Scientists from the Institut Pasteur, the CNRS, Inserm, Université de Paris and the Paris Public Hospital Network (AP-HP) determined the mechanisms involved in the loss of smell in patients infected with SARS-CoV-2 at different stages of the...
-
News | 2022.02.16
COVID-19: reducing outbreak risk with repeated antigen screening in healthcare facilities
With the emergence of the Omicron variant, healthcare facilities remain highly vulnerable to virus spread. Effective surveillance of viral presence in these facilities is therefore crucial and needs to be adapted according to outbreak risk. Scientists from the Institut Pasteur worked with colleagues to analyze the reactive use of antigen testing in a long-term care facility following a detected...
-
Document de presse | 2022.06.15
COVID-19: Identification of broadly SARS-CoV-2 neutralizing monoclonal antibodies
Although the different SARS-CoV-2 variants currently in circulation are undoubtedly less severe in vaccinated individuals in the general population, immunocompromised people are at greater risk of developing severe forms of COVID-19. Monoclonal antibodies currently offer the best approach, both as a preventive and curative treatment for these patients. Scientists from the Institut Pasteur and...
-
News | 2022.06.08
The role of social sciences in the response to an epidemic: the example of the COVID-19 pandemic
A lesser known but equally crucial dimension in managing and responding to an epidemic is social sciences in health, which can shed light on populations' understanding, perception and acceptance of the risks associated with diseases. The COVID-19 pandemic is no exception. As the disease spread across the planet, clear differences in perception by populations were observed in different countries,...
-
News | 2020.04.28
COVID-19 pandemic: The Institut Pasteur International Network collective effort
To this day, SARS-CoV2, the virus responsible for COVID-19 pandemic, has been identified in more than 180 countries. It unfolded a once-in-a-century public health crisis, through his extensive impact on global economy directly caused by confinement measures. To confront these challenges, the 32 member institutes of the Institut Pasteur International Network (IPIN) are swinging into...
-
News | 2020.04.28
COVID-19 pandemic: The Institut Pasteur International Network collective effort
To this day, SARS-CoV2, the virus responsible for COVID-19 pandemic, has been identified in more than 180 countries. It unfolded a once-in-a-century public health crisis, through his extensive impact on global economy directly caused by confinement measures. To confront these challenges, the 32 member institutes of the Institut Pasteur International Network (IPIN) are swinging into...
-
Document de presse | 2020.07.06
COVID-19: no cross-protective immunity conferred by other coronaviruses in children
Every winter, seasonal coronaviruses are responsible for repeated colds and bronchitis from early childhood onwards. The question of whether the four seasonal coronaviruses can confer cross-protective immunity for COVID-19 was recently raised when it was demonstrated that some individuals had antibodies and immunity cells recognizing the SARS-CoV-2 virus before it was in active circulation. The...
-
Document de presse | 2021.06.22
Drug repurposing to counter COVID-19: antiviral activity may be induced by phospholipidosis
Over the past 16 months and against the backdrop of the COVID-19 health crisis, thousands of drugs have been tested with a view to repurpose them to tackle SARS-CoV-2. Many of these drugs have demonstrated potential antiviral activity (23 compounds including hydroxychloroquine, azithromycin, amiodarone and 4 others tested in clinical trials). Given this high number of potential treatments, the...
